Izon Science
Izon delivers precision TRPS‑based analysis and SEC‑based isolation platforms for nanoparticles, accelerating EV and nanomedicine research.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Izon delivers precision TRPS‑based analysis and SEC‑based isolation platforms for nanoparticles, accelerating EV and nanomedicine research.
NanomedicineDiagnosticsTherapeutics
Technology Platform
Izon’s core technologies are tunable resistive pulse sensing (TRPS) for single‑particle analysis and size‑exclusion chromatography (SEC) qEV columns for high‑purity nanoparticle isolation.
Opportunities
Rising demand for EV‑based biomarkers, LNP quality control for mRNA therapeutics, and cGMP‑compatible nanoparticle purification present strong growth avenues.
Risk Factors
Adoption depends on regulatory acceptance of EV diagnostics and competition from larger instrumentation firms offering alternative measurement technologies.
Competitive Landscape
Key competitors include Malvern Panalytical, Nanoscale Instruments, and Particle Metrix; Izon differentiates through its unique TRPS technology and integrated SEC isolation platform.